SCHEMBL9503195

SCHEMBL9503195

CC(N)NN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclopropane SCHEMBL9142093 0.88
SCHEMBL56411 0.74
SCHEMBL22619241 0.70
SCHEMBL7939880 0.70
SCHEMBL16976243 0.70
SCHEMBL310224 0.70
SCHEMBL17122597 0.70
SCHEMBL16731312 0.70
SCHEMBL487298 0.70
SCHEMBL3374972 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117603250-A Method for preparing isocyanate from polycarbonate 诠达化学股份有限公司 2024-02-27 CN claimed
CN-1052662-A Use has the amine catalysis of ring structure metallic phosphate condensation catalysts UNION CARBIDE CHEM PLASTIC (US) 1991-07-03 CN claimed
WO-2023248696-A1 PIEZOELECTRIC FILM, PIEZOELECTRIC ELEMENT, ELECTROACOUSTIC TRANSDUCER, AND METHOD FOR MANUFACTURING PIEZOELECTRIC FILM 富士フイルム株式会社 2023-12-28 WO disclosed
EP-3901162-A1 GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF AbbVie Inc. (US) 2021-10-27 EP disclosed
WO-2017207776-A1 SYSTEM FOR DISPENSING A COSMETIC PRODUCT L'OREAL (FR) 2017-12-07 WO disclosed
WO-2017007612-A1 METHODS TO INDUCE TARGETED PROTEIN DEGRADATION THROUGH BIFUNCTIONAL MOLECULES DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-01-12 WO disclosed
WO-2016105518-A1 METHODS TO INDUCE TARGETED PROTEIN DEGRADATION THROUGH BIFUNCTIONAL MOLECULES DANA-FARBER CANCER INSTITUTE, INC. (US) 2016-06-30 WO disclosed
US-20140378516-A1 COMPOSITIONS, METHODS OF USE, AND METHODS OF TREATMENT UNIVERSITY OF SOUTH FLORIDA 2014-12-25 US disclosed
US-8673881-B2 Compositions and methods for the treatment of inflammation A.T. Resolve Sarl (CH) 2014-03-18 US disclosed
EP-2695881-A1 GUANIDINE COMPOUND Astellas Pharma Inc. (JP) 2014-02-12 EP disclosed
EP-2017279-B1 AMINOPYRIMIDINE DERIVATIVES HAVING AURORA-A-SELECTIVE INHIBITORY ACTIVITY MSD KK (JP) 2013-09-04 EP disclosed
US-20120270739-A1 METHOD FOR SAMPLE ANALYSIS OF ANEUPLOIDIES IN MATERNAL SAMPLES VERINATA HEALTH, INC. (US) 2012-10-25 US disclosed
US-7169489-B2 Hydrogen storage, distribution, and recovery system FUELSELL TECHNOLOGIES, INC. (US) 2007-01-30 US disclosed
US-5264179-A Scavengers comprising starch derivatives KURITA WATER INDUSTRIES LTD. (JP) 1993-11-23 US disclosed
EP-0114002-B1 BENZOTHIOPYRANO(4,3,2,-CD)INDAZOLES, THEIR PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR PRODUCTION WARNER-LAMBERT COMPANY (US) 1987-03-04 EP disclosed
EP-0114002-A2 Benzothiopyrano(4,3,2,-cd)indazoles, their pharmaceutical compositions and methods for their production WARNER-LAMBERT COMPANY (US) 1984-07-25 EP disclosed